NCT03420807View on ClinicalTrials.gov

Retinal Metabolic Imaging of Alzheimer Patient

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

December 4, 2017

Primary Completion Date

March 12, 2020

Study Completion Date

March 12, 2020

Conditions
Alzheimer Disease
Interventions
DEVICE

MHRC

Evaluate the feasibility of detection of beta-amyloid plaques by using their spectral signature in autofluorescence or reflectance.

Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

Sponsors
All Listed Sponsors
collaborator

McGill University

OTHER

collaborator

Sunnybrook Health Sciences Centre

OTHER

lead

Optina Diagnostics Inc.

INDUSTRY

NCT03420807 - Retinal Metabolic Imaging of Alzheimer Patient | Biotech Hunter | Biotech Hunter